Universe · entity
Integral Health Asset Management, LLC
Institutional manager (13F) · CIK 1773206
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $1.7B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | INSMED INC | $245M | 1,500,000 |
| 2 | REVOLUTION MEDICINES INC | $146M | 1,500,000 |
| 3 | CYTOKINETICS INC | $105M | 1,600,000 |
| 4 | REGENERON PHARMACEUTICALS | $66M | 85,000 |
| 5 | VERA THERAPEUTICS INC | $64M | 1,600,000 |
| 6 | CARDINAL HEALTH INC | $57M | 270,000 |
| 7 | ROIVANT SCIENCES LTD | $55M | 2,000,000 |
| 8 | BRIGHTSPRING HEALTH SVCS INC | $53M | 1,250,000 |
| 9 | RHYTHM PHARMACEUTICALS INC | $52M | 600,000 |
| 10 | MERCK & CO INC | $51M | 425,000 |
| 11 | EDGEWISE THERAPEUTICS INC | $50M | 1,600,000 |
| 12 | ASTRAZENECA PLC | $49M | 250,000 |
| 13 | ALIGNMENT HEALTHCARE INC | $45M | 2,575,000 |
| 14 | NOVARTIS AG | $38M | 250,000 |
| 15 | BOSTON SCIENTIFIC CORP | $35M | 550,000 |
| 16 | LIFESTANCE HEALTH GROUP INC | $27M | 4,300,000 |
| 17 | ASCENDIS PHARMA A/S | $26M | 115,000 |
| 18 | SCHOLAR ROCK HLDG CORP | $25M | 500,000 |
| 19 | ELEVANCE HEALTH INC FORMERLY | $22M | 75,000 |
| 20 | CENTENE CORP DEL | $21M | 650,000 |
| 21 | BRIDGEBIO PHARMA INC | $20M | 275,000 |
| 22 | MINERALYS THERAPEUTICS INC | $20M | 750,000 |
| 23 | NEUROCRINE BIOSCIENCES INC | $20M | 150,000 |
| 24 | GLAUKOS CORP | $19M | 175,000 |
| 25 | ARROWHEAD PHARMACEUTICALS IN | $19M | 300,000 |
| 26 | VERTEX PHARMACEUTICALS INC | $18M | 40,000 |
| 27 | ORIC PHARMACEUTICALS INC | $18M | 1,400,000 |
| 28 | ALUMIS INC | $18M | 800,000 |
| 29 | FRESENIUS MEDICAL CARE AG | $17M | 775,000 |
| 30 | INTUITIVE SURGICAL INC | $16M | 35,000 |
| 31 | UNIQURE NV | $15M | 900,000 |
| 32 | TARSUS PHARMACEUTICALS INC | $14M | 200,000 |
| 33 | GILEAD SCIENCES INC | $14M | 100,000 |
| 34 | ELI LILLY & CO | $14M | 15,000 |
| 35 | EDWARDS LIFESCIENCES CORP | $14M | 170,000 |
| 36 | COGENT BIOSCIENCES INC | $13M | 350,000 |
| 37 | ELANCO ANIMAL HEALTH INC | $13M | 550,000 |
| 38 | MADRIGAL PHARMACEUTICALS INC | $13M | 25,000 |
| 39 | PRAXIS PRECISION MEDICINES I | $13M | 40,000 |
| 40 | DIANTHUS THERAPEUTICS INC | $13M | 150,000 |
| 41 | REGENXBIO INC | $13M | 1,500,000 |
| 42 | QUEST DIAGNOSTICS INC | $12M | 60,000 |
| 43 | XENON PHARMACEUTICALS INC | $12M | 200,000 |
| 44 | ERASCA INC | $11M | 700,000 |
| 45 | ALTO NEUROSCIENCE INC | $11M | 500,000 |
| 46 | BIOGEN INC | $11M | 60,000 |
| 47 | DEXCOM INC | $11M | 175,000 |
| 48 | SOLENO THERAPEUTICS INC | $11M | 325,000 |
| 49 | DISC MEDICINE INC | $11M | 170,000 |
| 50 | NURIX THERAPEUTICS INC | $11M | 700,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.